This company has been acquired
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Tyme Technologies Toekomstige groei
Future criteriumcontroles 0/6
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Biotechs winstgroei | 27.9% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Syros, Tyme Technologies jump more than 20% after hours as shareholders approve merger
Sep 15We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Aug 05
TYME stock surges on merger agreement and Syros Pharmaceuticals
Jul 05Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
May 26We Think Tyme Technologies (NASDAQ:TYME) Can Afford To Drive Business Growth
Mar 19Tyme Technologies Offers Incredible Risk-Reward
Dec 07Here's Why We're Not Too Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Nov 19Tyme Technologies: The Market Missed The Bullish Memo
Aug 27We're Not Very Worried About Tyme Technologies' (NASDAQ:TYME) Cash Burn Rate
Jul 19Tyme Technologies reports FY results
Jun 10Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount
May 29Here's Why We're Watching Tyme Technologies' (NASDAQ:TYME) Cash Burn Situation
Mar 26Have Tyme Technologies, Inc. (NASDAQ:TYME) Insiders Been Selling Their Stock?
Feb 19
Tyme falls after equity offer as quarterly data indicate liquidity pressure
Feb 04Tyme stock granted U.S. patent claims for using TYME-19 to treat COVID-19 infections
Feb 03Do Institutions Own Tyme Technologies, Inc. (NASDAQ:TYME) Shares?
Feb 02Revisiting Tyme Technologies
Dec 17Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently?
Dec 16Is Tyme Technologies (NASDAQ:TYME) In A Good Position To Invest In Growth?
Dec 09Tyme Technologies names new finance chief
Nov 30In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Tyme Technologies onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2022 | N/A | -24 | -20 | -20 | N/A |
| 3/31/2022 | N/A | -24 | -21 | -21 | N/A |
| 12/31/2021 | N/A | -24 | -19 | -19 | N/A |
| 9/30/2021 | N/A | -25 | -21 | -21 | N/A |
| 6/30/2021 | N/A | -26 | -23 | -23 | N/A |
| 3/31/2021 | N/A | -29 | -24 | -24 | N/A |
| 12/31/2020 | N/A | -28 | -24 | -24 | N/A |
| 9/30/2020 | N/A | -28 | -23 | -23 | N/A |
| 6/30/2020 | N/A | -28 | -20 | -20 | N/A |
| 3/31/2020 | N/A | -22 | -20 | -20 | N/A |
| 12/31/2019 | N/A | -27 | -18 | -18 | N/A |
| 9/30/2019 | N/A | -29 | -19 | -19 | N/A |
| 6/30/2019 | N/A | -29 | -19 | -19 | N/A |
| 3/31/2019 | N/A | -33 | -20 | -20 | N/A |
| 12/31/2018 | N/A | -27 | -20 | -20 | N/A |
| 9/30/2018 | N/A | -25 | -17 | -17 | N/A |
| 6/30/2018 | N/A | -23 | -15 | -15 | N/A |
| 3/31/2018 | N/A | -19 | -12 | -12 | N/A |
| 12/31/2017 | N/A | -17 | -10 | -10 | N/A |
| 9/30/2017 | N/A | -14 | -9 | -9 | N/A |
| 6/30/2017 | N/A | -12 | -7 | -7 | N/A |
| 3/31/2017 | N/A | -15 | -6 | -6 | N/A |
| 12/31/2016 | N/A | -17 | -6 | -6 | N/A |
| 6/30/2016 | N/A | -13 | -6 | -6 | N/A |
| 3/31/2016 | N/A | -11 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -12 | N/A | -7 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if TYME's forecast earnings growth is above the savings rate (1.9%).
Winst versus markt: Insufficient data to determine if TYME's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if TYME's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if TYME's revenue is forecast to grow faster than the US market.
Hoge groei-inkomsten: Insufficient data to determine if TYME's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if TYME's Return on Equity is forecast to be high in 3 years time